Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07021027
EARLY_PHASE1

Eggs and Age-related Macular Degeneration (EggsAMD) Study.

Sponsor: Kathryn Starr

View on ClinicalTrials.gov

Summary

Age-related macular degeneration (AMD) is the primary cause of vision loss in people over the age of 55. Currently, no cure is available for individuals suffering from AMD. The purpose of this pilot study is to evaluate the feasibility of implementing a 5-month egg intervention in adults with intermediate AMD. The objective of this research study is to evaluate the feasibility of a whole egg (2 or 4 per day) intervention in older adults with intermediate AMD. The secondary objective of this research is to determine descriptive statistics, change over time and estimate effect sizes for retinal sensitivity, and vision, cognition and physical function. By completing these research objectives, the researchers hope to gain preliminary evidence in support of a larger trial that will assess the impact of egg consumption on eye health in adults with AMD.

Official title: Feasibility Study of Whole Egg Consumption in Adults With Intermediate Age-related Macular Degeneration

Key Details

Gender

All

Age Range

55 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-06-18

Completion Date

2026-09-30

Last Updated

2026-01-07

Healthy Volunteers

No

Interventions

DRUG

Whole Egg - 4

Participants will be asked to consume 4 medium Eggland's Best eggs per day for 5 months.

DRUG

Whole Egg - 2

Participants will be asked to consume 2 medium Eggland's Best eggs per day for 5 months.

Locations (1)

Duke Center for Living

Durham, North Carolina, United States